Chen YX[au] - Search Results

Year	Number of Results
1980	2
1981	2
1984	2
1985	7
1986	6
1987	1
1988	3
1989	3
1990	5
1991	3
1993	6
1994	3
1995	6
1996	3
1998	3
1999	2
2000	11
2001	5
2002	6
2003	37
2004	47
2005	49
2006	58
2007	58
2008	62
2009	59
2010	56
2011	67
2012	81
2013	90
2014	77
2015	81
2016	98
2017	113
2018	105
2019	121
2020	118
2021	145
2022	114

1

Comprehensive review of targeted therapy for colorectal cancer.

Xie YH, Chen YX, Fang JY. Xie YH, et al. Among authors: chen yx. Signal Transduct Target Ther. 2020 Mar 20;5(1):22. doi: 10.1038/s41392-020-0116-z. Signal Transduct Target Ther. 2020. PMID: 32296018 Free PMC article. Review.

2

F. nucleatum targets lncRNA ENO1-IT1 to promote glycolysis and oncogenesis in colorectal cancer.

Hong J, Guo F, Lu SY, Shen C, Ma D, Zhang X, Xie Y, Yan T, Yu T, Sun T, Qian Y, Zhong M, Chen J, Peng Y, Wang C, Zhou X, Liu J, Liu Q, Ma X, Chen YX, Chen H, Fang JY. Hong J, et al. Among authors: chen yx. Gut. 2021 Nov;70(11):2123-2137. doi: 10.1136/gutjnl-2020-322780. Epub 2020 Dec 14. Gut. 2021. PMID: 33318144

3

LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer.

Wang Y, Lu JH, Wu QN, Jin Y, Wang DS, Chen YX, Liu J, Luo XJ, Meng Q, Pu HY, Wang YN, Hu PS, Liu ZX, Zeng ZL, Zhao Q, Deng R, Zhu XF, Ju HQ, Xu RH. Wang Y, et al. Among authors: chen yx. Mol Cancer. 2019 Dec 2;18(1):174. doi: 10.1186/s12943-019-1105-0. Mol Cancer. 2019. PMID: 31791342 Free PMC article.

4

A novel faecal Lachnoclostridium marker for the non-invasive diagnosis of colorectal adenoma and cancer.

Liang JQ, Li T, Nakatsu G, Chen YX, Yau TO, Chu E, Wong S, Szeto CH, Ng SC, Chan FKL, Fang JY, Sung JJY, Yu J. Liang JQ, et al. Among authors: chen yx. Gut. 2020 Jul;69(7):1248-1257. doi: 10.1136/gutjnl-2019-318532. Epub 2019 Nov 27. Gut. 2020. PMID: 31776231 Free PMC article.

5

TRAPPC4 regulates the intracellular trafficking of PD-L1 and antitumor immunity.

Ren Y, Qian Y, Ai L, Xie Y, Gao Y, Zhuang Z, Chen J, Chen YX, Fang JY. Ren Y, et al. Among authors: chen yx. Nat Commun. 2021 Sep 13;12(1):5405. doi: 10.1038/s41467-021-25662-9. Nat Commun. 2021. PMID: 34518538 Free PMC article.

6

A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma.

Zhao WH, Liu J, Wang BY, Chen YX, Cao XM, Yang Y, Zhang YL, Wang FX, Zhang PY, Lei B, Gu LF, Wang JL, Yang N, Zhang R, Zhang H, Shen Y, Bai J, Xu Y, Wang XG, Zhang RL, Wei LL, Li ZF, Li ZZ, Geng Y, He Q, Zhuang QC, Fan XH, He AL, Zhang WG. Zhao WH, et al. Among authors: chen yx. J Hematol Oncol. 2018 Dec 20;11(1):141. doi: 10.1186/s13045-018-0681-6. J Hematol Oncol. 2018. PMID: 30572922 Free PMC article. Clinical Trial.

7

Cardiac ryanodine receptor calcium release deficiency syndrome.

Sun B, Yao J, Ni M, Wei J, Zhong X, Guo W, Zhang L, Wang R, Belke D, Chen YX, Lieve KVV, Broendberg AK, Roston TM, Blankoff I, Kammeraad JA, von Alvensleben JC, Lazarte J, Vallmitjana A, Bohne LJ, Rose RA, Benitez R, Hove-Madsen L, Napolitano C, Hegele RA, Fill M, Sanatani S, Wilde AAM, Roberts JD, Priori SG, Jensen HK, Chen SRW. Sun B, et al. Among authors: chen yx. Sci Transl Med. 2021 Feb 3;13(579):eaba7287. doi: 10.1126/scitranslmed.aba7287. Sci Transl Med. 2021. PMID: 33536282

8

Glial Metabolic Rewiring Promotes Axon Regeneration and Functional Recovery in the Central Nervous System.

Li F, Sami A, Noristani HN, Slattery K, Qiu J, Groves T, Wang S, Veerasammy K, Chen YX, Morales J, Haynes P, Sehgal A, He Y, Li S, Song Y. Li F, et al. Among authors: chen yx. Cell Metab. 2020 Nov 3;32(5):767-785.e7. doi: 10.1016/j.cmet.2020.08.015. Epub 2020 Sep 16. Cell Metab. 2020. PMID: 32941799 Free PMC article.

9

Radiation Therapy Promotes Hepatocellular Carcinoma Immune Cloaking via PD-L1 Upregulation Induced by cGAS-STING Activation.

Du SS, Chen GW, Yang P, Chen YX, Hu Y, Zhao QQ, Zhang Y, Liu R, Zheng DX, Zhou J, Fan J, Zeng ZC. Du SS, et al. Among authors: chen yx. Int J Radiat Oncol Biol Phys. 2022 Apr 1;112(5):1243-1255. doi: 10.1016/j.ijrobp.2021.12.162. Epub 2022 Jan 2. Int J Radiat Oncol Biol Phys. 2022. PMID: 34986380

10

Alteration in TET1 as potential biomarker for immune checkpoint blockade in multiple cancers.

Wu HX, Chen YX, Wang ZX, Zhao Q, He MM, Wang YN, Wang F, Xu RH. Wu HX, et al. Among authors: chen yx. J Immunother Cancer. 2019 Oct 17;7(1):264. doi: 10.1186/s40425-019-0737-3. J Immunother Cancer. 2019. PMID: 31623662 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results